Karin Hehenberger, United States
Transplant Recipient Perspective - Where Are Endpoints and New Therapies Falling Short?

Bill Fitzsimmons, United States
Comparing and Contrasting Expedited Development Pathways in US, EU, and ROW

Timothy Schroeder, United States
Strategies for Developing a New Therapeutic in Multinational Trials to Address the Needs of Global Regulators

Stefan Schneeberger, Austria
Kidney NMP and Trial Perspectives and Endpoints